Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

1.

Enhancing natural killer cells is beneficial in multiple sclerosis - Commentary.

Segal BM.

Mult Scler. 2018 Nov 13:1352458518809296. doi: 10.1177/1352458518809296. [Epub ahead of print] No abstract available.

PMID:
30421650
2.

CNS-resident classical DCs play a critical role in CNS autoimmune disease.

Giles DA, Duncker PC, Wilkinson NM, Washnock-Schmid JM, Segal BM.

J Clin Invest. 2018 Dec 3;128(12):5322-5334. doi: 10.1172/JCI123708. Epub 2018 Oct 29.

3.

An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE.

Stoolman JS, Duncker PC, Huber AK, Giles DA, Washnock-Schmid JM, Soulika AM, Segal BM.

J Neuroinflammation. 2018 Jul 16;15(1):208. doi: 10.1186/s12974-018-1237-y.

4.

A randomized, subject and rater-blinded, placebo-controlled trial of dimethyl fumarate for obstructive sleep apnea.

Braley TJ, Huber AK, Segal BM, Kaplish N, Saban R, Washnock-Schmid JM, Chervin RD.

Sleep. 2018 Aug 1;41(8). doi: 10.1093/sleep/zsy109.

PMID:
29800466
5.

Modulation of the Innate Immune System: A Future Approach to the Treatment of Neurological Disease.

Segal BM.

Clin Immunol. 2018 Apr;189:1-3. doi: 10.1016/j.clim.2018.03.003. No abstract available.

PMID:
29628125
6.
7.

GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System-Infiltrating Cells, but Is Dispensable for Disease Induction.

Duncker PC, Stoolman JS, Huber AK, Segal BM.

J Immunol. 2018 Feb 1;200(3):966-973. doi: 10.4049/jimmunol.1701484. Epub 2017 Dec 29.

PMID:
29288202
8.

Myeloid cell plasticity in the evolution of central nervous system autoimmunity.

Giles DA, Washnock-Schmid JM, Duncker PC, Dahlawi S, Ponath G, Pitt D, Segal BM.

Ann Neurol. 2018 Jan;83(1):131-141. doi: 10.1002/ana.25128. Epub 2018 Jan 14.

PMID:
29283442
9.

CD4+ T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis.

Neal LM, Xing E, Xu J, Kolbe JL, Osterholzer JJ, Segal BM, Williamson PR, Olszewski MA.

MBio. 2017 Nov 21;8(6). pii: e01415-17. doi: 10.1128/mBio.01415-17.

10.

Speaking out about gender imbalance in invited speakers improves diversity.

Klein RS, Voskuhl R, Segal BM, Dittel BN, Lane TE, Bethea JR, Carson MJ, Colton C, Rosi S, Anderson A, Piccio L, Goverman JM, Benveniste EN, Brown MA, Tiwari-Woodruff SK, Harris TH, Cross AH.

Nat Immunol. 2017 Apr 18;18(5):475-478. doi: 10.1038/ni.3707. No abstract available.

11.

Effect of Template Reporting of Brain MRIs for Multiple Sclerosis on Report Thoroughness and Neurologist-Rated Quality: Results of a Prospective Quality Improvement Project.

Dickerson E, Davenport MS, Syed F, Stuve O, Cohen JA, Rinker JR, Goldman MD, Segal BM, Foerster BR; Michigan Radiology Quality Collaborative.

J Am Coll Radiol. 2017 Mar;14(3):371-379.e1. doi: 10.1016/j.jacr.2016.09.037. Epub 2016 Dec 5.

PMID:
27932248
12.

IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation.

Cravens PD, Hussain RZ, Miller-Little WA, Ben LH, Segal BM, Herndon E, Stüve O.

PLoS One. 2016 Oct 25;11(10):e0165248. doi: 10.1371/journal.pone.0165248. eCollection 2016.

13.

An emerging role for eotaxins in neurodegenerative disease.

Huber AK, Giles DA, Segal BM, Irani DN.

Clin Immunol. 2018 Apr;189:29-33. doi: 10.1016/j.clim.2016.09.010. Epub 2016 Sep 21.

PMID:
27664933
14.

Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.

Douglas JN, Gardner LA, Salapa HE, Lalor SJ, Lee S, Segal BM, Sawchenko PE, Levin MC.

J Neuroinflammation. 2016 Jul 8;13(1):178. doi: 10.1186/s12974-016-0647-y.

15.

T-bet promotes the accumulation of encephalitogenic Th17 cells in the CNS.

Grifka-Walk HM, Segal BM.

J Neuroimmunol. 2017 Mar 15;304:35-39. doi: 10.1016/j.jneuroim.2016.05.007. Epub 2016 May 24.

16.

Stable biomarker for plastic microglia.

Segal BM, Giger RJ.

Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):3130-2. doi: 10.1073/pnas.1601669113. Epub 2016 Mar 10. No abstract available.

17.

CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis.

Phares TW, DiSano KD, Stohlman SA, Segal BM, Bergmann CC.

Brain Behav Immun. 2016 May;54:128-139. doi: 10.1016/j.bbi.2016.01.016. Epub 2016 Jan 18.

18.

Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Carbajal KS, Mironova Y, Ulrich-Lewis JT, Kulkarni D, Grifka-Walk HM, Huber AK, Shrager P, Giger RJ, Segal BM.

J Immunol. 2015 Sep 15;195(6):2552-9. doi: 10.4049/jimmunol.1501097. Epub 2015 Aug 3.

19.

IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23.

Grifka-Walk HM, Giles DA, Segal BM.

Eur J Immunol. 2015 Oct;45(10):2780-6. doi: 10.1002/eji.201545800. Epub 2015 Aug 14.

20.

The dual roles of immunity in ALS: injury overrides protection.

Murdock BJ, Bender DE, Segal BM, Feldman EL.

Neurobiol Dis. 2015 May;77:1-12. doi: 10.1016/j.nbd.2015.02.017. Epub 2015 Feb 26. Review.

PMID:
25726748

Supplemental Content

Loading ...
Support Center